Abstract:Tumors pose a significant threat to human health, and their occurrence and fatality rates are on the rise each year. Accurate tumor diagnosis is crucial in preventing untimely treatment and late-stage metastasis, thereby reducing mortality. To address this, we have developed a novel type of hybrid nanogels called γ-Fe2O3@PNIPAM/PAm/CTS, which contain iron oxide nanoparticles and poly(N-isopropyl acrylamide)/poly(acrylamide)/chitosan. The rational for this study relies on the concept that thermosensitive PNIPAM has the ability to contract when exposed to the elevated temperature conditions found within tumors. This contraction leads to a dense clustering of the high-loading γ-Fe2O3 nanoparticles within the nanogel, thus greatly enhancing the capabilities of MRI imaging. Additionally, the amino groups in chitosan on the particle surface can be converted into ammonium salts under mildly acidic conditions, allowing for an increase in the charge of the nanogel specifically at the slightly acidic tumor site. Consequently, it promotes the phagocytosis of tumor cells and effectively enhances the accumulation and retention of nanogels at the tumor site. The synthesis of the hybrid nanogels involves a surfactant-free emulsion copolymerization process, where vinyl-modified γ-Fe2O3 superparamagnetic nanoparticles are copolymerized with the monomers in the presence of chitosan. We have optimized various reaction parameters to achieve a high loading content of the superparamagnetic nanoparticles, reaching up to 60%. The achieved r2 value of 517.74 mM-1S-1 significantly surpasses that of the clinical imaging contrast agent Resovist (approximately 151 mM-1S-1). To assess the performance of these magnetic nanogels, we conducted experiments using Cal27 oral tumors and 4T1 breast tumors in animal models. The nanogels exhibited temperature- and pH-sensitivity, enabling magnetic targeting and enhancing diagnosis through MRI imaging. The results demonstrated the potential of these hybrid nanogels as contrast agents for magnetic targeting in biomedical applications.

Dynamically Reversible Iron Oxide Nanoparticle Assemblies For Targeted Amplification Of T1-Weighted Magnetic Resonance Imaging Of Tumors

Tumor Acid Microenvironment-Triggered Self-Assembly of ESIONPs for T1/T2 Switchable Magnetic Resonance Imaging

Tumour Microenvironment-Responsive Semiconducting Polymer-Based Self-Assembling Nanotheranostics

Extremely Small Iron Oxide Nanoparticles with Ph-Dependent Solubility Transition As T1/T2 Switchable Contrast Agents for MRI

Ligand‐Mediated Magnetism‐Conversion Nanoprobes for Activatable Ultra‐High Field Magnetic Resonance Imaging

Hypoxia-Responsive Aggregation of Iron Oxide Nanoparticles for T1-to-T2 Switchable Magnetic Resonance Imaging of Tumors

Redox-triggered Aggregation of ESIONPs with Switchable T1 to T2 Contrast Effect for T2-weighted Magnetic Resonance Imaging.

Manganese-based magnetic layered double hydroxide nanoparticle: a pH-sensitive and concurrently enhanced T1/T2-weighted dual-mode magnetic resonance imaging contrast agent for accurate cancer diagnosis

Hypoxia-Responsive T<sub>2</sub>-to-T<sub>1</sub> Dynamically Switchable Extremely Small Iron Oxide Nanoparticles for Sensitive Tumor Imaging In Vivo

Synergistic Regulation of Longitudinal and Transverse Relaxivity of Extremely Small Iron Oxide Nanoparticles (esionps) Using Ph-Responsive Nanoassemblies.

A rapid-response smart nanoplatform with dual T1-T2 activation for acidic microenvironment imaging

Manganese Oxide/metal-Organic Frameworks-Based Nanocomposites for Tumr Micro-environment Sensitive 1H/19F Dual-mode Magnetic Resonance Imaging in Vivo

Iron oxide nanoclusters formed by acid-induced in situ calcium ion cross-linking for targeted magnetic resonance imaging of glioblastoma

Hypoxia-Responsive T 2 -to-T 1 Dynamically Switchable Extremely Small Iron Oxide Nanoparticles for Sensitive Tumor Imaging In Vivo

An Adaptable Nanoplatform for Integrating Anatomic and Functional Magnetic Resonance Imaging under a 3.0 T Magnetic Field

In vivo aggregation-induced transition between T 1 and T 2 relaxations of magnetic ultra-small iron oxide nanoparticles in tumor microenvironment.

Redox-Sensitive Clustered Ultrasmall Iron Oxide Nanoparticles for Switchable T2/T1-Weighted Magnetic Resonance Imaging Applications

Tumor micro-environment sensitive 19F-magnetic resonance imaging in vivo

Enhancing MRI imaging through high loading of superparamagnetic nanogels with high sensitivity to the tumor environment

Iron oxide/manganese oxide co-loaded hybrid nanogels as pH-responsive magnetic resonance contrast agents.

Fe3O4 Nanoparticles Functionalized with Polymer Ligand for T-1-Weighted MRI in Vitro and in Vivo